Dudediligence.

Stablecoin Development Corporat

SDEVAMEX · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

50.6M

on 2026-06-30, from 183K on 2024-03-31 10-Q ↗

Earlier counts are adjusted for the 1-for-35 and 1-for-5 reverse splits; each bar's tip shows the count as filed.

a raise that quarter, at its price

Newest

$200.0M

S-3 of 2025-10-03. 1 prospectus supplement filed under it since. S-3 ↗

$100.0M

Agreement of 2026-01-20. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

167.55B

Warrants of every class as tagged in the XBRL facts on 2026-06-30, exercise price $0.06. 10-Q ↗

Cash

2.3 quarters

$7.0M on 2026-06-30 ÷ $3.0M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2026-01-16Private placement incl. 837.70M pre-funded1,675,392,260not read$134.0M8-K ↗
2025-10-09Private placement441,325not read$9.8M8-K ↗
2025-08-19Private placement481,250$8.00$3.9M8-K ↗

Also on file: a 1-for-2 reverse split, 2025-08-19 8-K ↗ · a 1-for-5 reverse split, 2026-02-20 8-K ↗